Prenatal Exposure to Methamphetamine and Its Association With Birth Outcomes: A Meta‐Analysis
Birth Defects Research · 2025
DOI: 10.1002/bdr2.2488 ↗At a glance
Metaanalyse in Birth Defects Research, 2025. Written by Nima Rastegar-Pouyani and 7 co-authors. Institution: Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS), Tehran, Iran. Major MEDLINE topics: Methamphetamine, Prenatal Exposure Delayed Effects. 32 references.
Abstract (original language)
Purpose
The growing prevalence of methamphetamine abuse has been regarded as a matter of great concern due to its damaging impact on public health worldwide. Our study aimed to perform a systematic review of the literature with meta‐analysis to evaluate the association between prenatal methamphetamine exposure, Preterm Birth (PTB) Low Birth Weight (LBW), and being Small for Gestational Age (SGA). Later on, we investigated the association between prenatal methamphetamine use and the aforementioned birth defects.
Methods
We conducted a systematic search of English‐language articles in Web of Science, Scopus, and PubMed from inception to December 24, 2021, identifying 1223 observational studies. After removing duplicates, 911 articles remained for title and abstract screening, of which 868 were excluded. Following a full‐text review of 43 studies, 35 were excluded due to insufficient data, leaving eight studies for meta‐analysis. Data were analyzed using Stata 15.0, with Odds Ratio (OR) (95% Confidence Intervals (CI)) as effect sizes. Subgroup analysis was performed by sample type (urine, meconium, and …), and heterogeneity was assessed using the Chi‐square test ( I 2 more than 50% was considered heterogenic), applying fixed‐ or random‐effects models accordingly. Publication bias was evaluated via Egger's test and funnel plots, and sensitivity analysis was conducted to assess result robustness.
Results
Prenatal exposure to methamphetamine was found to be associated with PTB (OR 2.64; 95% CI 1.89–3.70), LBW (OR 2.83; 95% CI 1.09–7.38), and SGA (OR 1.44; 95% CI 1.04–1.99).
Conclusion
Our meta‐analysis shows a substantial association between prenatal exposure to methamphetamine and PTB, LBW, and being SGA.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
- Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
- Health and Environment Research Center, Ilam University of Medical Sciences, Ilam, Iran.
- Department of Occupational Health Engineering, School of Health, Ilam University of Medical Sciences, Ilam, Iran.
ORCID profiles: Nima Rastegar-Pouyani, Nader Rahimi
Cite
APA
Rastegar-Pouyani, N., Fakhari, F., Lalani, A. R., Jafarzadeh, E., Zafari, R., Rahimi, N., Habibian Sezavar, A., & Ostad, S. N. (2025). Prenatal Exposure to Methamphetamine and Its Association With Birth Outcomes: A Meta‐Analysis. Birth Defects Research. https://doi.org/10.1002/bdr2.2488
Vancouver
Rastegar-Pouyani N, Fakhari F, Lalani AR, Jafarzadeh E, Zafari R, Rahimi N, et al. Prenatal Exposure to Methamphetamine and Its Association With Birth Outcomes: A Meta‐Analysis. Birth Defects Research. 2025. doi:10.1002/bdr2.2488
BibTeX
@article{RastegarPouyani2025,
author = {Rastegar-Pouyani, Nima and Fakhari, Fatemeh and Lalani, Armineh Rezagholi and Jafarzadeh, Emad and Zafari, Reza and Rahimi, Nader and Habibian Sezavar, Ahmad and Ostad, Seyed Nasser},
title = {Prenatal Exposure to Methamphetamine and Its Association With Birth Outcomes: A Meta‐Analysis},
journal = {Birth Defects Research},
year = {2025},
doi = {10.1002/bdr2.2488}
}
EUVIMED